Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Telemonitoring of Blood Pressure in Local Pharmacies

Key facts

Where
Solbiate Arno, ItalySee the site

Where in Italy

  • Italian Institute of TelemedicineSolbiate Arno, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Italian Institute of Telemedicine
Trial code
NCT03781401
Record updated
4 November 2026
Original description
The TEMPLAR project is an observational, cross-sectional, multicenter study involving several community pharmacies spread all over Italy. The aim of the project, the currently largest Italian ABPM Registry, is to analyze the 24-hour ABPMs performed in community pharmacies enabled for this service in accordance with the current Italian regulations, in order to evaluate the level of BP control in the community and to provide scientific evidence on the usefulness of a telehealth network involving the pharmacist for the screening and control of hypertension.Read full original descriptionShow less

Blood Pressure Telemonitoring in Local Pharmacies and Blood Pressure Control in the Community

The TEMPLAR project is an observational, cross-sectional, multicenter study involving several community pharmacies spread all over Italy. The aim of the project, the currently largest Italian ABPM Registry, is to analyze the 24-hour ABPMs performed in community pharmacies enabled for this service in accordance with the current Italian regulations, in order to evaluate the level of BP control in the community and to provide scientific evidence on the usefulness of a telehealth network involving the pharmacist for the screening and control of hypertension.

Inclusion: Consecutive patients of both sexes and of any age; Conventional clinical indications for ABPM (either treated with antihypertensive drugs or untreated).

Exclusion: None.

ClinicalTrials.gov NCT03781401